Myelodysplastic Syndrome in a Case of New-onset Pancytopenia

Ian Lancaster; Deep Patel; Vikas Sethi; Weston Connelly; Joseph Namey

Myelodysplastic Syndrome in a Case of New-onset Pancytopenia

Ian Lancaster
, Deep Patel
, Vikas Sethi
, Weston Connelly
, Joseph Namey

HCA Florida Largo Hospital

HCA Healthcare

Research output: Contribution to journal › Article › peer-review

Abstract

Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.

Original language	American English
Journal	Internal Medicine
State	Published - Mar 1 2022

Keywords

myelodysplastic syndrome
pancytopenia
piperacillin/tazobactam‐induced immune response
vaccine‐associated pancytopenia

Disciplines

Hemic and Lymphatic Diseases
Internal Medicine

Access to Document

https://doi.org/10.1002/ccr3.5533

Cite this

@article{a1ff797f8e5d4c20b1379e6b99127f9b,

title = "Myelodysplastic Syndrome in a Case of New-onset Pancytopenia",

abstract = " Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.",

keywords = "myelodysplastic syndrome, pancytopenia, piperacillin/tazobactam‐induced immune response, vaccine‐associated pancytopenia",

author = "Ian Lancaster and Deep Patel and Vikas Sethi and Weston Connelly and Joseph Namey",

note = "Lancaster I, Patel D, Sethi V, Connelly W, Namey J. Myelodysplastic syndrome in a case of new-onset pancytopenia. Clin Case Rep. 2022;10(3):e05533. doi:10.1002/ccr3.5533",

year = "2022",

month = mar,

day = "1",

language = "American English",

journal = "Internal Medicine",

}

TY - JOUR

T1 - Myelodysplastic Syndrome in a Case of New-onset Pancytopenia

AU - Lancaster, Ian

AU - Patel, Deep

AU - Sethi, Vikas

AU - Connelly, Weston

AU - Namey, Joseph

N1 - Lancaster I, Patel D, Sethi V, Connelly W, Namey J. Myelodysplastic syndrome in a case of new-onset pancytopenia. Clin Case Rep. 2022;10(3):e05533. doi:10.1002/ccr3.5533

PY - 2022/3/1

Y1 - 2022/3/1

N2 - Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.

AB - Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new-onset pancytopenia following administration of a COVID-19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.

KW - myelodysplastic syndrome

KW - pancytopenia

KW - piperacillin/tazobactam‐induced immune response

KW - vaccine‐associated pancytopenia

UR - https://scholarlycommons.hcahealthcare.com/internal-medicine/330

UR - https://doi.org/10.1002/ccr3.5533

M3 - Article

JO - Internal Medicine

JF - Internal Medicine

ER -

Myelodysplastic Syndrome in a Case of New-onset Pancytopenia

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this